跳至主要内容
临床试验/NCT07029256
NCT07029256招募中不适用

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年7月26日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
100
试验地点
2
主要终点
Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage

研究概览

简要总结

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
  • Prior abdominal imaging

排除标准

  • History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

结局指标

主要结局

Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage

时间窗: Baseline (after completion of bladder surgery)

The radiology-assessed tumor stage from the ultrasound (US) and the core needle biopsy-assessed tumor stage will be compared with the final pathologic tumor stage.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验